| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Feld | EVP Chief Revenue Officer | 2026-02-26 | 75 | $181.84 | $13.64kSell |
| Bertram L. Scott | Director | 2026-02-18 | 953 | $182.61 | $174.03kSell |
| Michael Feld | EVP CRO Pres. Life Sciences | 2026-01-26 | 75 | $202.73 | $15.20kSell |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-01-15 | 3,054 | $167.91 | $512.80kBuy |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-01-15 | 2,454 | $209.00 | $512.89kSell |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-01-15 | 1,010 | $206.54 | $208.61kSell |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-01-15 | 600 | $209.00 | $125.40kSell |
| Michael Feld | EVP CRO Pres. Life Sciences | 2025-12-26 | 74 | $196.08 | $14.51kSell |
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2025-12-17 | 629 | $196.03 | $123.30kSell |
| Michael Feld | EVP CRO Pres. Life Sciences | 2025-12-01 | 75 | $193.36 | $14.50kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 12.88% | 36,678,939 | $5.86B | Institution |
| Blackrock Inc | 9.71% | 27,648,705 | $4.41B | Institution |
| T Rowe Price Investment Management Inc | 5.05% | 14,378,219 | $2.30B | Institution |
| State Street Corp | 4.91% | 13,989,132 | $2.23B | Institution |
| First Eagle Investment Management LLC | 4.09% | 11,646,000 | $1.86B | Institution |
| Massachusetts Financial Services Co | 3.33% | 9,486,694 | $1.51B | Institution |
| Geode Capital Management LLC | 2.42% | 6,885,361 | $1.10B | Institution |
| Wellington Management Group LLP | 1.86% | 5,299,030 | $845.88M | Institution |
| Franklin Resources Inc | 1.84% | 5,244,303 | $837.15M | Institution |
| Price T Rowe Associates Inc | 1.50% | 4,279,200 | $683.09M | Institution |